Private Equity Bet on German Drugmaker Goes South Quickly

(Bloomberg) -- A hefty bet on a German cancer drug maker is proving a major headache for Swedish investment firm EQT, one of a slew of companies seeking to capitalize on Europe’s fast-growing direc...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.